Discovery and Characterization of a Peptoid with Antifungal Activity against Cryptococcus neoformans

ACS Medicinal Chemistry Letters

Volumn 7, Issue 12, 2016, Pages 1139-1144

  Corson, Ashley E ^a   Armstrong, Scott A ^a   Wright, Matthew E ^a   McClelland, Erin E ^a   Bicker, Kevin L ^a  

^a MIDDLE TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Cryptococcus neoformans; fungal infections; high throughput screening; Peptoids

Indexed keywords

PEPTOID;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; CRYPTOCOCCUS NEOFORMANS; CYTOTOXICITY; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG POTENCY; DRUG STABILITY; HUMAN; HUMAN CELL; IC50; MAMMAL CELL; MIC50; NONHUMAN; PRIORITY JOURNAL;

EID: 85002762920     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/acsmedchemlett.6b00338     Document Type: Article

References (38)

1. Brandt, M. E.; Park, B. J. Think Fungus-Prevention and Control of Fungal Infections Emerging Infect. Dis. 2013, 19 ( 10 ) 1688-1689 10.3201/eid1910.131092
2. Mikulska, M.; Bono, V. D.; Ratto, S.; Viscoli, C. Occurrence, Presentation and Treatment of Candidemia Expert Rev. Clin. Immunol. 2012, 8 ( 8 ) 755-765 10.1586/eci.12.52
3. Sloan, D. J.; Parris, V. Cryptococcal meningitis: epidemiology and therapeutic options Clin. Epidemiol. 2014, 6, 169-182 10.2147/CLEP.S38850
4. Azie, N.; Neofytos, D.; Pfaller, M.; Meier-Kriesche, H.-U.; Quan, S.-P.; Horn, D. The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012 Diagn. Microbiol. Infect. Dis. 2012, 73 ( 4 ) 293-300 10.1016/j.diagmicrobio.2012.06.012
5. Srikanta, D.; Santiago-Tirado, F. H.; Doering, T. L. Cryptococcus neoformans: Historical curiosity to modern pathogen Yeast 2014, 31 ( 2 ) 47-60 10.1002/yea.2997
6. Park, B. J.; Wannemuehler, K. A.; Marston, B. J.; Govender, N.; Pappas, P. G.; Chiller, T. M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS AIDS 2009, 23 ( 4 ) 525-530 10.1097/QAD.0b013e328322ffac
7. Datta, K.; Bartlett, K. H.; Baer, R.; Byrnes, E.; Galanis, E.; Heitman, J.; Hoang, L.; Leslie, M. J.; MacDougall, L.; Magill, S. S.; Morshed, M. G.; Marr, K. A. Spread of Cryptococcus gattii into Pacific Northwest Region of the United States Emerging Infect. Dis. 2009, 15 ( 8 ) 1185 10.3201/eid1508.081384
8. Pappas, P. G.; Kauffman, C. A.; Andes, D.; Benjamin, D. K.; Calandra, T. F.; Edwards, J. E.; Filler, S. G.; Fisher, J. F.; Kullberg, B.-J.; Zeichner, L. O.; Reboli, A. C.; Rex, J. H.; Walsh, T. J.; Sobe, J. D. Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America Clin. Infect. Dis. 2009, 48 ( 5 ) 503-535 10.1086/596757
9. Perfect, J. R.; Dismukes, W. E.; Dromer, F.; Goldman, D. L.; Graybill, J. R.; Hamill, R. J.; Harrison, T. S.; Larsen, R. A.; Lortholary, O.; Nguyen, M.-H.; Pappas, P. G.; Powderly, W. G.; Singh, N.; Sobel, J. D.; Sorrell, T. C. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America Clin. Infect. Dis. 2010, 50 ( 3 ) 291-322 10.1086/649858
10. Walsh, T. J.; Anaissie, E. J.; Denning, D. W.; Herbrecht, R.; Kontoyiannis, D. P.; Marr, K. A.; Morrison, V. A.; Segal, B. H.; Steinbach, W. J.; Stevens, D. A.; van Burik, J.-A.; Wingard, J. R.; Patterson, T. F. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America Clin. Infect. Dis. 2008, 46 ( 3 ) 327-360 10.1086/525258
11. Hanson, K. E.; Alexander, B. D.; Perfect, J. Drug Resistance in Cryptococcus neoformans. In Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects; Mayers, D. L., Ed.; Humana Press: Totowa, NJ, 2009; pp 967-985.
12. Matejuk, A.; Leng, Q.; Begum, M. D.; Woodle, M. C.; Scaria, P.; Chou, S. T.; Mixson, A. J. Peptide-based Antifungal Therapies against Emerging Infections Drugs Future 2010, 35 ( 3 ) 197-197 10.1358/dof.2010.035.03.1452077
13. Latham, P. W. Therapeutic peptides revisited Nat. Biotechnol. 1999, 17 ( 8 ) 755-757 10.1038/11686
14. Zuckermann, R. N.; Kerr, J. M.; Kent, S. B. H.; Moos, W. H. Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis J. Am. Chem. Soc. 1992, 114 ( 26 ) 10646-10647 10.1021/ja00052a076
15. Culf, A. S.; Ouellette, R. J. Solid-phase synthesis of N-substituted glycine oligomers (alpha-peptoids) and derivatives Molecules 2010, 15 ( 8 ) 5282-335 10.3390/molecules15085282
16. Chongsiriwatana, N. P.; Miller, T. M.; Wetzler, M.; Vakulenko, S.; Karlsson, A. J.; Palecek, S. P.; Mobashery, S.; Barron, A. E. Short Alkylated Peptoid Mimics of Antimicrobial Lipopeptides Antimicrob. Agents Chemother. 2011, 55 ( 1 ) 417-420 10.1128/AAC.01080-10
17. Chongsiriwatana, N. P.; Patch, J. A.; Czyzewski, A. M.; Dohm, M. T.; Ivankin, A.; Gidalevitz, D.; Zuckermann, R. N.; Barron, A. E. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides Proc. Natl. Acad. Sci. U. S. A. 2008, 105 ( 8 ) 2794-9 10.1073/pnas.0708254105
18. Chongsiriwatana, N. P.; Wetzler, M.; Barron, A. E. Functional synergy between antimicrobial peptoids and peptides against Gram-negative bacteria Antimicrob. Agents Chemother. 2011, 55 ( 11 ) 5399-402 10.1128/AAC.00578-11
19. Kapoor, R.; Eimerman, P. R.; Hardy, J. W.; Cirillo, J. D.; Contag, C. H.; Barron, A. E. Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis Antimicrob. Agents Chemother. 2011, 55 ( 6 ) 3058-62 10.1128/AAC.01667-10
20. Kapoor, R.; Wadman, M. W.; Dohm, M. T.; Czyzewski, A. M.; Spormann, A. M.; Barron, A. E. Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms Antimicrob. Agents Chemother. 2011, 55 ( 6 ) 3054-7 10.1128/AAC.01516-10
21. Patch, J. A.; Barron, A. E. Helical peptoid mimics of magainin-2 amide J. Am. Chem. Soc. 2003, 125 ( 40 ) 12092-3 10.1021/ja037320d
22. Uchida, M.; McDermott, G.; Wetzler, M.; Le Gros, M. A.; Myllys, M.; Knoechel, C.; Barron, A. E.; Larabell, C. A. Soft X-ray tomography of phenotypic switching and the cellular response to antifungal peptoids in Candida albicans Proc. Natl. Acad. Sci. U. S. A. 2009, 106 ( 46 ) 19375-19380 10.1073/pnas.0906145106
23. Galetti, M. D.; Cirigliano, A. M.; Cabrera, G. M.; RamÃrez, J. A. Multicomponent synthesis of acylated short peptoids with antifungal activity against plant pathogens Mol. Diversity 2012, 16 ( 1 ) 113-119 10.1007/s11030-011-9334-1
24. Figliozzi, G. M.; Goldsmith, R.; Ng, S. C.; Banville, S. C.; Zuckermann, R. N. Synthesis of N-substituted glycine peptoid libraries. In Methods in Enzymology; Academic Press: 1996; Vol. 267, pp 437-447.
25. Kennedy, J. P.; Williams, L.; Bridges, T. M.; Daniels, R. N.; Weaver, D.; Lindsley, C. W. Application of Combinatorial Chemistry Science on Modern Drug Discovery J. Comb. Chem. 2008, 10 ( 3 ) 345-354 10.1021/cc700187t
26. Lam, K. S.; Lebl, M.; Krchnak, V. The One-Bead-One-Compound Combinatorial Library Method Chem. Rev. 1997, 97 ( 2 ) 411-448 10.1021/cr9600114
27. Fisher, K. J.; Turkett, J. A.; Corson, A. E.; Bicker, K. L. Peptoid Library Agar Diffusion (PLAD) assay for the high-throughput identification of antimicrobial peptoids ACS Comb. Sci. 2016, 18 ( 6 ) 287-291 10.1021/acscombsci.6b00039
28. Janbon, G.; Ormerod, K. L.; Paulet, D.; Byrnes, E. J., III; Yadav, V.; Chatterjee, G.; Mullapudi, N.; Hon, C.-C.; Billmyre, R. B.; Brunel, F.; Bahn, Y.-S.; Chen, W.; Chen, Y.; Chow, E. W. L.; Coppee, J.-Y.; Floyd-Averette, A.; Gaillardin, C.; Gerik, K. J.; Goldberg, J.; Gonzalez-Hilarion, S.; Gujja, S.; Hamlin, J. L.; Hsueh, Y.-P.; Ianiri, G.; Jones, S.; Kodira, C. D.; Kozubowski, L.; Lam, W.; Marra, M.; Mesner, L. D.; Mieczkowski, P. A.; Moyrand, F.; Nielsen, K.; Proux, C.; Rossignol, T.; Schein, J. E.; Sun, S.; Wollschlaeger, C.; Wood, I. A.; Zeng, Q.; Neuveglise, C.; Newlon, C. S.; Perfect, J. R.; Lodge, J. K.; Idnurm, A.; Stajich, J. E.; Kronstad, J. W.; Sanyal, K.; Heitman, J.; Fraser, J. A.; Cuomo, C. A.; Dietrich, F. S. Analysis of the Genome and Transcriptome of Cryptococcus neoformans var. grubii Reveals Complex RNA Expression and Microevolution Leading to Virulence Attenuation PLoS Genet. 2014, 10 ( 4 ) e1004261 10.1371/journal.pgen.1004261
29. Lennox, K. A.; Marion, J. T.; Deborah, A. W.; Okey, N.; Peter, N. K.; Somsit, T.; Boonchuay, E.; Achara, C.; Reller, L. B.; William, R. J.; Gerri, S. H.; Gary, W. P. Antifungal Susceptibilities of Cryptococcus neoformans Emerging Infect. Dis. 2004, 10 ( 1 ) 143 10.3201/eid1001.020779
30. Bisson, G. P.; Nthobatsong, R.; Thakur, R.; Lesetedi, G.; Vinekar, K.; Tebas, P.; Bennett, J. E.; Gluckman, S.; Gaolathe, T.; MacGregor, R. R. The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana JAIDS, J. Acquired Immune Defic. Syndr. 2008, 49 ( 2 ) 227-229 10.1097/QAI.0b013e318183181e
31. Desnos-Ollivier, M.; Patel, S.; Raoux-Barbot, D.; Heitman, J.; Dromer, F. Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation mBio 2015, 6 ( 3 ) e00311-15 10.1128/mBio.00311-15
32. Kavanaugh, L. A.; Fraser, J. A.; Dietrich, F. S. Recent Evolution of the Human Pathogen Cryptococcus neoformans by Intervarietal Transfer of a 14-Gene Fragment Mol. Biol. Evol. 2006, 23 ( 10 ) 1879-1890 10.1093/molbev/msl070
33. McClelland, E. E.; Casadevall, A. Strain-related differences in antibody-mediated changes in gene expression are associated with differences in capsule and location of binding Fungal Genet. Biol. 2012, 49 ( 3 ) 227-234 10.1016/j.fgb.2012.01.006
34. Reese, A. J.; Yoneda, A.; Breger, J. A.; Beauvais, A.; Liu, H.; Griffith, C. L.; Bose, I.; Kim, M.-J.; Skau, C.; Yang, S.; Sefko, J. A.; Osumi, M.; Latge, J.-P.; Mylonakis, E.; Doering, T. L. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence Mol. Microbiol. 2007, 63 ( 5 ) 1385-1398 10.1111/j.1365-2958.2006.05551.x
35. Masuda, A.; Kondo, M.; Saito, T.; Yatabe, Y.; Kobayashi, T.; Okamoto, M.; Suyama, M.; Takahashi, T.; Takahashi, T. Establishment of Human Peripheral Lung Epithelial Cell Lines (HPL1) Retaining Differentiated Characteristics and Responsiveness to Epidermal Growth Factor, Hepatocyte Growth Factor, and Transforming Growth Factor beta1 Cancer Res. 1997, 57 ( 21 ) 4898-4904
36. MarvinSketch, 16.6.20.0; ChemAxon, 2016, (http://www.chemaxon.com).
37. Camp, D.; Garavelas, A.; Campitelli, M. Analysis of Physicochemical Properties for Drugs of Natural Origin J. Nat. Prod. 2015, 78 ( 6 ) 1370-1382 10.1021/acs.jnatprod.5b00255
38. Otvos, L., Jr.; Vetter, S.; Koladia, M.; Knappe, D.; Schmidt, R.; Ostorhazi, E.; Kovalszky, I.; Bionda, N.; Cudic, P.; Surmacz, E.; Wade, J.; Hoffmann, R. The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor Amino Acids 2014, 46 ( 4 ) 873-882 10.1007/s00726-013-1650-6